Eledon Pharmaceuticals, Inc. filed its 10-K/A on Aug 19, 2024 for the period ending Dec 31, 2023. In this report its auditor, KMJ Corbin & Company LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.530 USD | +0.89% |
|
-3.62% | +9.95% |

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ELDN Stock
- News Eledon Pharmaceuticals, Inc.
- Eledon Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt